NASDAQ: EXAS 14.80
Change: +0.26 +1.79% Minimum 20 min delay
9:57 AM ET on Dec 09, 2016
Volume: 149,731

OUR FIRST MISSION:

To work with patients, payers & providers to help play a role in the eradication of colorectal cancer.

Exact Sciences Laboratories

How our lab’s technologies and efficiencies carry Cologuard from arrival to result.

The Exact Science of Customer Care

Supporting patients and driving compliance is a science all its own. Learn how we practice it.

Tennis Anyone?

How Cologuard's keeping Steve Rubin on the court and bringing physicians into play.

Latest Financial Reports

Current Corporate Presentation

Corporate Presentation - November 2016 October 26, 2016
Download (PDF 1.50 MB)